Effect of metabolic therapy on the course of heart failure in patients after myocarditis complicated with systemic connecting tissue diseases
Kuriata, A.V.; Karavanskaia, I.L.; Pavlichenko, N.A.
Likars'ka Sprava 2010(5-6): 109-116
2010
ISSN/ISBN: 1019-5297 PMID: 21488376 Document Number: 639511
In the course of observation over 40 patients after an old myocarditis against general systemic diseases of connective tissue who had been given a pharmacotherapy regarding main disease and a chronic heart failure, additionally Vazonat (campaign of "Olajnfarm", Latvia), preparation of the myocardial cytoprotection was prescribed in a therapeutic dose of 500 mg per day. Vazonat inclusion in basic therapy during 1 month was accompanied by improvement of a clinical condition of the patients, reduction of heart failure signs, and improvement of life quality.